Browse Studies — Arctuva

Phase 1

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

This multi-center randomized controlled trial will assess the safety and efficacy of ATG followed by either adalimumab or verapamil in preserving insulin secre…

Type 1 DiabetesNew Onset

Estimated

~$10 – $6,250

City of Hope Medical CenterNCT07061574

Phase 3

Comparing the Effects of Anakinra and Tocilizumab on Outcomes in Patients With New-Onset Refractory Status Epilepticus

The goal of this clinical trial is to find out whether two existing medications-anakinra and tocilizumab-can effectively treat a rare and life-threatening brai…

New Onset Refractory Status EpilepticusNew-Onset Refractory Status EpilepticusFebrile Infection-Related Epilepsy Syndrome (FIRES)

Estimated

~$10 – $6,250

Yale UniversityNCT07281027

Phase 4

A Phase 4, Open-Label, Prospective, Single-Group, Multicenter Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adult Participants With New-Onset Generalized Myasthenia Gravis

The main purpose of this study is to measure how well adults with new-onset gMG (which means they've had generalized disease signs and/or symptoms for less tha…

New Onset Generalized Myasthenia Gravis (gMG)

Estimated

~$10 – $7,500

argenxNCT06909214

Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry

The purpose of the Long term Evaluation of Cardiac Arrhythmias after Transcatheter Aortic Valve Implantation (LOCATE) Registry is to perform long-term ambulato…

Aortic StenosisAtrial Fibrillation New OnsetHeart Block

Estimated

~$10 – $750

Kansas City Heart Rhythm Research FoundationNCT06055751